FDA should consider drug-therapy regimens
Science
.
2024 Dec 20;386(6728):1356-1357.
doi: 10.1126/science.adt1480.
Epub 2024 Dec 19.
Authors
Eero Castrén
1
,
Claus Normann
2
Affiliations
1
Neuroscience Center, Helsinki Institute of Life Science University of Helsinki, Helsinki, Finland.
2
Department of Psychiatry and Psychotherapy, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
PMID:
39700281
DOI:
10.1126/science.adt1480
No abstract available
Publication types
Letter